7. Notes Payable

Our debt obligations are as follows (in thousands):

 

 

 

 

 

As of December 31,

 

 

 

Interest Rate (1)

 

2024

 

 

2023

 

Monroe Term Loan (2)

 

9.71%

 

$

54,000

 

 

$

53,501

 

PNC ABL Facility (3)

 

6.33%

 

 

23,109

 

 

 

13,245

 

PNC Equipment Term Loan (4)

 

7.23%

 

 

2,729

 

 

 

 

Green Remedies Promissory Note (5)

 

3.00%

 

 

564

 

 

 

1,101

 

Total notes payable

 

 

 

 

80,402

 

 

 

67,847

 

Less: Current portion of long-term debt

 

 

 

 

(1,651

)

 

 

(1,159

)

Less: Unamortized debt issuance costs

 

 

 

 

(2,171

)

 

 

(1,345

)

Less: Unamortized OID

 

 

 

 

(83

)

 

 

(186

)

Less: Unamortized OID warrant

 

 

 

 

(232

)

 

 

(519

)

Notes payable, net

 

 

 

$

76,265

 

 

$

64,638

 

 

 

 

 

 

 

 

 

 

(1) Interest rates as of December 31, 2024

 

 

 

 

 

 

(2) Bears interest based on SOFR plus Applicable Margin ranging from 4.5% to 5.5%

 

(3) Bears interest based on Term SOFR plus a margin of 2.0%

 

 

 

 

 

 

(4) Bears interest based on Term SOFR plus a margin of 2.75%

 

 

 

 

 

 

(5) Stated interest rate of 3.0%

 

 

 

 

 

 

The future minimum principal payments as of December 31, 2024 are as follows (in thousands):

 

Year Ending December 31,

 

Amount

 

2025

 

$

1,651

 

2026

 

 

1,142

 

2027

 

 

1,115

 

2028

 

 

1,114

 

2029

 

 

24,080

 

Thereafter

 

 

51,300

 

Total

 

$

80,402

 

 

We capitalize financing costs we incur related to implementing our debt arrangements. We record these debt issuance costs associated with our revolving credit facility and our term loan as a reduction of long-term debt, net and amortize them over the contractual life of the related debt arrangements. The table below summarizes changes in debt issuance costs (in thousands).

 

 

 

 

 

December 31,

 

 

 

 

 

2024

 

 

2023

 

Debt issuance costs

 

 

 

 

 

 

 

 

Beginning balance

 

 

 

$

1,345

 

 

$

2,123

 

Financing costs deferred

 

 

 

 

1,513

 

 

 

 

Less: Amortization expense

 

 

 

 

(687

)

 

 

(778

)

Debt issuance costs, net of accumulated amortization

 

 

 

$

2,171

 

 

$

1,345

 

PNC Credit Facility

On August 5, 2020, QRHC and certain of its subsidiaries entered into a Loan, Security and Guaranty Agreement (the “PNC Loan Agreement”), which was most recently amended on December 30, 2024, with BBVA USA (which was subsequently succeeded in interest by PNC Bank, National Association (“PNC”)), as a lender, and as administrative agent, collateral agent, and issuing bank, which provides for a credit facility (the “ABL Facility”) comprising an asset-based revolving credit facility in the maximum principal amount of $45.0 million with a sublimit for issuance of letters of credit of up to $3.5 million. The revolving credit facility bears interest, at the borrowers’ option, at either the Base Rate, plus a margin of 1.0% (no borrowings as of December 31, 2024), or the Term SOFR Rate for the interest period in effect plus a margin of 2.0% (6.33% as of December 31, 2024). The maturity date of the revolving credit facility is December 30, 2029. The PNC Loan Agreement also provides for an additional equipment term loan facility in the maximum principal amount of $3.0 million.

As further discussed in Note 4, Property and Equipment, net and Other Assets, we drew $2.9 million on an equipment term loan (“Fourth Amendment Term Loan”) in 2024 to fund 80% of the aggregate purchase price of certain compactors and related equipment. The Fourth Amendment Term Loan bears interest, at the borrower’s option, at either the Base Rate, plus a margin of 1.75%, or the Term SOFR Rate for the interest period in effect plus a margin of 2.75% (7.23% at December 31, 2024). The Fourth Amendment Term Loan will amortize in equal quarterly installments of $143,650 of the senior secured term loan facility with the remaining balance payable on December 30, 2029.

Certain of QRHC’s subsidiaries are the borrowers under the PNC Loan Agreement. QRHC and one of its subsidiaries are guarantors under the PNC Loan Agreement. As security for the obligations of the borrowers under the PNC Loan Agreement, (i) the borrowers under the PNC Loan Agreement have granted a first priority lien on substantially all of their tangible and intangible personal property, including a pledge of the capital stock and membership interests, as applicable, of certain of QRHC’s direct and indirect subsidiaries, and (ii) the guarantors under the PNC Loan Agreement have granted a first priority lien on the capital stock and membership interests, as applicable, of certain of QRHC’s direct and indirect subsidiaries.

The PNC Loan Agreement contains certain financial covenants, including a minimum fixed charge coverage ratio. In addition, the PNC Loan Agreement contains negative covenants limiting, among other things, additional indebtedness, transactions with affiliates, additional liens, sales of assets, dividends, investments and advances, prepayments of debt, mergers and acquisitions, and other matter customarily restricted in such agreements. The PNC Loan Agreement also contains customary events of default, including payment defaults, breaches of representations and warranties, covenant defaults, events of bankruptcy and insolvency, change of control, and failure of any guaranty or security document supporting the PNC Loan Agreement to be in full force and effect. Upon the occurrence of an event of default, the outstanding obligations under the PNC Loan Agreement may be accelerated and become immediately due and payable.

As of December 31, 2024, the ABL Facility borrowing base availability was $45.0 million, of which $23.1 million principal was outstanding.

Monroe Term Loan

On October 19, 2020, QRHC and certain of its subsidiaries entered into a Credit Agreement (the “Credit Agreement”), dated as of October 19, 2020, which was most recently amended on December 30, 2024, with Monroe Capital Management Advisors, LLC (“Monroe Capital”), as administrative agent for the lenders thereto. Among other things, the Credit Agreement provides for the following:

A senior secured term loan facility in the principal amount of $54.0 million as of December 31, 2024. The senior secured term loan accrues interest at the SOFR Rate for SOFR Loans plus the Applicable Margin; provided, that if the provision of SOFR Loans becomes unlawful or unavailable, then interest will be payable at a rate per annum equal to the Base Rate from time to time in effect plus the Applicable Margin for Base Rate Loans. The maturity date of the term loan facility is June 28, 2030 (the “Maturity Date”). The senior secured term loan will amortize in aggregate annual amounts equal to 1.00% of the original principal amount of the senior secured term loan facility with the balance payable on the Maturity Date.
A delayed draw term loan facility in the maximum principal amount of $25.0 million. Loans under the delayed draw term loan facility may be requested at any time until December 30, 2026. Proceeds of the delayed draw term loan are permitted to be used for Permitted Acquisitions.

Certain of QRHC’s subsidiaries are the borrowers under the Credit Agreement. QRHC is the guarantor under the Credit Agreement. As security for the obligations of the borrowers under the Credit Agreement, (i) the borrowers under the Credit Agreement have granted a first priority lien on substantially all of their tangible and intangible personal property, including a pledge of the capital stock and membership interests, as applicable, of certain of QRHC’s direct and indirect subsidiaries, and (ii) the guarantors under the Credit Agreement have granted a first priority lien on the capital stock and membership interests, as applicable, of QRHC’s direct and indirect subsidiaries.

The Credit Agreement contains certain financial covenants, including a minimum fixed charge coverage ratio and a senior net leverage ratio. In addition, the Credit Agreement contains negative covenants limiting, among other things, additional indebtedness, transactions with affiliates, additional liens, sales of assets, dividends, investments and advances, prepayments of debt, mergers and acquisitions, and other matters customarily restricted in such agreements. The Credit Agreement also contains customary events of default, including payment defaults, breaches of representations and warranties, covenant defaults, events of bankruptcy and insolvency, change of control, and failure of any guaranty or security document supporting the Credit Agreement to be in full force and effect. Upon the occurrence of an event of default, the outstanding obligations under the Credit Agreement may be accelerated and become immediately due and payable.

At the same time as the borrowing of the initial $11.5 million under the Credit Agreement in October 2020, in a separate agreement, we issued Monroe Capital a warrant to purchase 500,000 shares of QRHC’s common stock exercisable immediately. For the delayed draw term loan facility, we issued a separate warrant to purchase 350,000 shares upon drawing on this facility on October 19, 2021. Both warrants have an exercise price of $1.50 per share and an expiration date of March 19, 2028. We estimated the grant-date fair value of the warrants issued using the Black Scholes option pricing model and recorded a debt discount of approximately $766 thousand in 2020 for the 500,000-share warrant and $536 thousand in 2021 for the 350,000-share warrant which are being amortized over the term of the Credit Agreement. We also executed a letter agreement that provides that the warrant holder will receive minimum net proceeds of $1 million less any net proceeds received from the sale of the warrant shares, which is conditional on the full exercise and sale of all the warrant shares at the same time.

Green Remedies Promissory Note

On October 19, 2020, we issued an unsecured subordinated promissory note to the seller of Green Remedies in the aggregate principal amount of $2.7 million, payable commencing on January 1, 2021 in quarterly installments through October 1, 2025 and subject to an interest rate of 3.0% per annum.

Interest Expense

The amount of interest expense related to borrowings for the years ended December 31, 2024 and 2023 was $8.1 million and $7.8 million, respectively. Interest expense related to amortization of debt issuance fees, debt discount costs and interest related to vendor supply chain financing programs was $2.2 million and $1.9 million for the years ended December 31, 2024 and 2023, respectively.

Historical Timeline

Fiscal YearFiled
2024Mar 12, 2025Showing above
2015Mar 16, 2016

About Debt Disclosures

Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.

Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.